NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
The technology will be offered through Invitrogen's PD-Direct offering.
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.
Financial details were not disclosed.